Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gregory Friberg
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma
European Urology
Urology
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
Efficacy of Cryoablation Combined With Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
International Journal of Hyperthermia
Medicine
Cancer Research
Radiological
Physiology
Ultrasound Technology
Fludarabine Combined With Radiotherapy in Patients With Locally Advanced NSCLC Lung Carcinoma: A Phase I Study
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
A Phase I Open Label Study of the Farnesyltransferase Inhibitor CP-609,754 in Patients With Advanced Malignant Tumors
Clinical Cancer Research
Cancer Research
Oncology
Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
Clinical Genitourinary Cancer
Oncology
Urology
Sorafenib Combined With Hepatectomy in Patients With Intermediate-Stage and Advanced Hepatocellular Carcinoma
Archives of Medical Science
Medicine